Skip to main content
. 2024 Oct 25;103(43):e40257. doi: 10.1097/MD.0000000000040257

Table 6.

Comparison of inflammatory indicators between the 2 groups.

Group Experimental group (n = 62) Control group (n = 62) T value P value
PCT (µg/L) Pretreatment 116.12 ± 16.16 118.13 ± 15.77 -0.375 .708
7 days after treatment 75.12 ± 6.01* 80.51 ± 8.24* -4.130 <.001
IL-1β (pg/mL) Pretreatment 54.66 ± 19.63 55.46 ± 20.21 -0.306 .760
7 days after treatment 19.36 ± 10.22* 30.24 ± 11.23* -5.317 <.001
IL-6 (pg/mL) Pretreatment 84.62 ± 21.44 85.33 ± 23.51 -0.262 .794
7 days after treatment 34.31 ± 18.23* 48.14 ± 18.99* -4.441 <.001
IL-8 (pg/mL) Pretreatment 574.54 ± 132.16 571.46 ± 144.21 0.197 .844
7 days after treatment 236.54 ± 111.34* 316.77 ± 108.36* -5.831 <.001
TNF-α (pg/mL) Pretreatment 199.66 ± 40.26 202.64 ± 42.31 -0.398 .692
7 days after treatment 82.21 ± 24.41* 110.22 ± 28.21* -5.578 <.001

IL-1β, IL-6, IL-8 = interleukins, PCT = procalcitonin, TNF-α = tumor necrosis factor-alpha.

*

mean comparison with pretreatment P < 0.05.